Multiple myeloma, a form of cancer that impacts the bone marrow, is characterized by the excessive production of plasma cells that generate harmful proteins, which can cause damage to the kidneys. This condition predominantly affects individuals aged 60 and above, with a higher prevalence among African-Americans. Although the exact cause of multiple myeloma remains uncertain, early detection plays a crucial role in successful treatment. Unfortunately, diagnosing multiple myeloma poses challenges as the symptoms can greatly differ among patients and overlap with those of various other illnesses.
Bone Problems Associated with Multiple Myeloma
Multiple myeloma patients commonly face various bone issues, such as persistent pain in the chest and back. Although less frequent, individuals may also experience discomfort in their legs and arms. Additionally, many individuals with multiple myeloma develop osteoporosis, a condition characterized by a reduction in bone mass, leading to increased vulnerability to fractures. Shockingly, even minor incidents like a simple trip or fall from a low height can result in broken bones. It is estimated that up to 90% of multiple myeloma patients will experience bone damage as a consequence of the disease.
Understanding Anemia in Multiple Myeloma
Anemia is a medical condition characterized by a low red blood cell count or a deficiency of hemoglobin, the protein responsible for carrying oxygen throughout the body. It is commonly associated with symptoms such as fatigue and skin pallor. However, individuals diagnosed with multiple myeloma are particularly prone to developing anemia due to the detrimental effects of the cancer on the bone marrow, the vital organ responsible for producing red blood cells.
According to the International Myeloma Foundation, an alarming 60 to 70% of people already have anemia at the time of their multiple myeloma diagnosis. This statistic highlights the close connection between the two conditions and emphasizes the importance of addressing anemia in multiple myeloma patients as a crucial aspect of their overall treatment plan.